According to a new report North America Burn Ointment Market, published by KBV research, the North America Burn Ointment Market would witness market growth of 5% CAGR during the forecast period (2020-2026).
The US market dominated the North America Partial Thickness Burns Market by Country in 2019, and would continue to be a dominant market till 2026. The Canada market is exhibiting a CAGR of 6.7% during (2020 - 2026). Additionally, The Mexico market would witness a CAGR of 6.5% during (2020 - 2026).
The Topical Antibiotics market dominated the Canada Burn Ointment Market by Product in 2019, growing at a CAGR of 6.1 % during the forecast period. The Silver market is estimates to grow at a CAGR of 6.2% during (2020 - 2026). Additionally, The Iodine market would showcase highest CAGR of 6.6% during (2020 - 2026).
The Hospitals market dominated the Mexico Burn Ointment Market by End Use in 2019, thereby, achieving a market value of $22.1 Million by 2026. The Clinics market is experiencing a CAGR of 6.4% during (2020 - 2026). The Other End Use market is expected to witness a CAGR of 7.4% during (2020 - 2026).
Full Report: https://www.kbvresearch.com/north-america-burn-ointment-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Johnson and Johnson, ConvaTec Group PLC, Smith & Nephew PLC, GlaxoSmithKline PLC (GSK), Pfizer, Inc., Perrigo Company PLC, Sun Pharmaceutical Industries Ltd., Cipla Limited, Dr. Morepen Limited and Mankind Pharma Ltd.
By Depth of Burn
By Product
By End Use
By Country
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
